Auditor General launches audit of the procurement of onshore vaccine manufacturing facilities

The disconnect between the primary policy assumption underpinning the HTA Review, which is that products must be found safe and effective to be funded, demonstrates the extent of this MSAC outcome as a dangerous outlier.

“We’re looking at our approach to the funding, eligibility, and procurement of these vaccines to align with other vaccines that we fund and so we can continue keeping New Zealanders well,” said Pharmac chief executive Sarah Fitt.

New research shows that despite 82 per cent of women who have experienced menopause symptoms reporting impacts on their quality of life, many do not feel comfortable openly talking about what they are experiencing.

In its latest episode, TrailblAZers speaks with Professor Charlotte Hespe AM, the head of General Practice and Primary Care Research at Notre Dame University's School of Medicine.

The government could save billions by circumventing the regulatory process and funding unapproved health interventions. Of course, it does not do this because of the obvious risk to patient safety and public confidence in the health system. Why now?

The company said, "The outcome of the initial stage of an evaluation is not routinely communicated to the public whilst the TGA review process is ongoing, as it has been with lecanemab."

David Henderson,  the managing director for Biogen Australia and New Zealand, said, “This certification is more than just an accolade; it’s a reflection of our collective effort in creating a workplace where every voice is heard."

Tanya van der Wall, country managing director of Commercial Eyes, said, “We are excited to collaborate with Opyl and leverage their advanced AI capabilities to enhance the innovative data-driven insights we provide to our clients."

In debating the right and wrong of public hospitals cooking up copies of approved nuclear medicine therapies, this country must contemplate the broader consequences, including of any funding decision.

Health Minister Mark Butler is now considering funding a copy of a therapy, which the TGA has not and probably cannot lawfully consider, let alone approve.

AusBiotech is seeking mentors to guide and support up-and-coming startups as they navigate the commercialisation pipeline.

The industry must eschew its longstanding habit of treating policy engagement like a game of 'half-court tennis' in which it assumes the government shares its objectives in reform processes. You are not hitting the ball to yourself.

Many might forget that Medicines Australia secured a significant reform of comparator pricing in its 2017 agreement with the government.

Health Minister Mark Butler said, “The interim Australian Centre for Disease Control is leading this work – and is very focused on ensuring we are as prepared as possible for any potential case of H5N1 avian influenza.”

Democrat candidate Vice President Kamala Harris has announced a plan to dramatically expand the reforms implemented under the Inflation Reduction Act.

The TGA and South African Health Products Regulatory Authority have signed a Memorandum of Understanding that aims to strengthen collaboration between the two health product regulators.

Dementia Australia says the latest data from the Australian Bureau of Statistics highlights the urgent reality of dementia, revealing it is set to become the nation’s leading cause of death.

Eli Lilly general manager Tori Brown said, “The report highlights a once in a generation opportunity to act on Alzheimer’s disease. It is good for patients, good for families and carers, good for health and aged care systems, and good for the economy."

“It’s important to acknowledge the size of the issue and enormity of the challenge. Approximately 880,000 Australians are now living with a severe and complex mental illness,” said Dirk Otto, the general manager of Boehringer Ingelheim Australia